DM
MRTX
Deerfield Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-270,000
| Closed | -$22.2M | – | 136 |
|
|
2022
Q1 | $22.2M | Buy |
270,000
+182,000
| +207% | +$15M | 0.5% | 47 |
|
|
2021
Q4 | $12.9M | Buy |
+88,000
| New | +$12.9M | 0.27% | 74 |
|
|
2020
Q3 | – | Sell |
-179,885
| Closed | -$20.5M | – | 117 |
|
|
2020
Q2 | $20.5M | Sell |
179,885
-62,315
| -26% | -$7.11M | 0.6% | 57 |
|
|
2020
Q1 | $18.6M | Buy |
242,200
+68,200
| +39% | +$5.24M | 0.59% | 53 |
|
|
2019
Q4 | $22.4M | Sell |
174,000
-59,000
| -25% | -$7.6M | 0.72% | 45 |
|
|
2019
Q3 | $18.2M | Sell |
233,000
-31,600
| -12% | -$2.46M | 0.74% | 43 |
|
|
2019
Q2 | $27.3M | Buy |
264,600
+12,400
| +5% | +$1.28M | 0.98% | 33 |
|
|
2019
Q1 | $18.5M | Sell |
252,200
-622,286
| -71% | -$45.6M | 0.71% | 45 |
|
|
2018
Q4 | $37.1M | Buy |
874,486
+33,575
| +4% | +$1.42M | 1.48% | 23 |
|
|
2018
Q3 | $39.6M | Sell |
840,911
-459,454
| -35% | -$21.6M | 1.42% | 25 |
|
|
2018
Q2 | $64.1M | Buy |
1,300,365
+1,103,365
| +560% | +$54.4M | 2.25% | 5 |
|
|
2018
Q1 | $6.05M | Sell |
197,000
-178,000
| -47% | -$5.46M | 0.21% | 94 |
|
|
2017
Q4 | $6.84M | Buy |
+375,000
| New | +$6.84M | 0.27% | 78 |
|
|
2015
Q4 | – | Sell |
-110,049
| Closed | -$3.79M | – | 128 |
|
|
2015
Q3 | $3.79M | Sell |
110,049
-287,611
| -72% | -$9.9M | 0.15% | 98 |
|
|
2015
Q2 | $12.5M | Buy |
397,660
+364,748
| +1,108% | +$11.5M | 0.42% | 66 |
|
|
2015
Q1 | $965K | Buy |
+32,912
| New | +$965K | 0.03% | 109 |
|